Literature DB >> 27531651

Coincident signals from GPCRs and receptor tyrosine kinases are uniquely transduced by PI3Kβ in myeloid cells.

Daniel M Houslay1, Karen E Anderson1, Tamara Chessa1, Suhasini Kulkarni1, Ralph Fritsch2, Julian Downward3, Jonathan M Backer4, Len R Stephens5, Phillip T Hawkins5.   

Abstract

Class I phosphoinositide 3-kinases (PI3Ks) catalyze production of the lipid messenger phosphatidylinositol 3,4,5-trisphosphate (PIP3), which plays a central role in a complex signaling network regulating cell growth, survival, and movement. This network is overactivated in cancer and inflammation, and there is interest in determining the PI3K catalytic subunit (p110α, p110β, p110γ, or p110δ) that should be targeted in different therapeutic contexts. Previous studies have defined unique regulatory inputs for p110β, including direct interaction with Gβγ subunits, Rac, and Rab5. We generated mice with knock-in mutations of p110β that selectively blocked the interaction with Gβγ and investigated its contribution to the PI3K isoform dependency of receptor tyrosine kinase (RTK) and G protein (heterotrimeric guanine nucleotide-binding protein)-coupled receptor (GPCR) responses in primary macrophages and neutrophils. We discovered a unique role for p110β in supporting synergistic PIP3 formation in response to the coactivation of macrophages by macrophage colony-stimulating factor (M-CSF) and the complement protein C5a. In contrast, we found partially redundant roles for p110α, p110β, and p110δ downstream of M-CSF alone and a nonredundant role for p110γ downstream of C5a alone. This role for p110β completely depended on direct interaction with Gβγ, suggesting that p110β transduces GPCR signals in the context of coincident activation by an RTK. The p110β-Gβγ interaction was also required for neutrophils to generate reactive oxygen species in response to the Fcγ receptor-dependent recognition of immune complexes and for their β2 integrin-mediated adhesion to fibrinogen or poly-RGD+, directly implicating heterotrimeric G proteins in these two responses.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27531651      PMCID: PMC5417692          DOI: 10.1126/scisignal.aae0453

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  70 in total

Review 1.  The emerging mechanisms of isoform-specific PI3K signalling.

Authors:  Bart Vanhaesebroeck; Julie Guillermet-Guibert; Mariona Graupera; Benoit Bilanges
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04-09       Impact factor: 94.444

Review 2.  Membrane recognition by phospholipid-binding domains.

Authors:  Mark A Lemmon
Journal:  Nat Rev Mol Cell Biol       Date:  2008-02       Impact factor: 94.444

3.  Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation.

Authors:  Pascal Furet; Vito Guagnano; Robin A Fairhurst; Patricia Imbach-Weese; Ian Bruce; Mark Knapp; Christine Fritsch; Francesca Blasco; Joachim Blanz; Reiner Aichholz; Jacques Hamon; Doriano Fabbro; Giorgio Caravatti
Journal:  Bioorg Med Chem Lett       Date:  2013-05-14       Impact factor: 2.823

Review 4.  ITAM-based signaling beyond the adaptive immune response.

Authors:  Szabina Fodor; Zoltán Jakus; Attila Mócsai
Journal:  Immunol Lett       Date:  2005-11-28       Impact factor: 3.685

5.  Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages.

Authors:  Evangelia A Papakonstanti; Olivier Zwaenepoel; Antonio Bilancio; Emily Burns; Gemma E Nock; Benjamin Houseman; Kevan Shokat; Anne J Ridley; Bart Vanhaesebroeck
Journal:  J Cell Sci       Date:  2008-11-25       Impact factor: 5.285

6.  A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling.

Authors:  Zachary A Knight; Beatriz Gonzalez; Morri E Feldman; Eli R Zunder; David D Goldenberg; Olusegun Williams; Robbie Loewith; David Stokoe; Andras Balla; Balazs Toth; Tamas Balla; William A Weiss; Roger L Williams; Kevan M Shokat
Journal:  Cell       Date:  2006-04-27       Impact factor: 41.582

7.  Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110α (PIK3CA).

Authors:  John E Burke; Olga Perisic; Glenn R Masson; Oscar Vadas; Roger L Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

8.  Dynamic steps in receptor tyrosine kinase mediated activation of class IA phosphoinositide 3-kinases (PI3K) captured by H/D exchange (HDX-MS).

Authors:  John E Burke; Roger L Williams
Journal:  Adv Biol Regul       Date:  2012-09-13

9.  Molecular determinants of PI3Kγ-mediated activation downstream of G-protein-coupled receptors (GPCRs).

Authors:  Oscar Vadas; Hashem A Dbouk; Aliaksei Shymanets; Olga Perisic; John E Burke; Widian F Abi Saab; Bassem D Khalil; Christian Harteneck; Anne R Bresnick; Bernd Nürnberg; Jonathan M Backer; Roger L Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

10.  Long-term p110α PI3K inactivation exerts a beneficial effect on metabolism.

Authors:  Lazaros C Foukas; Benoit Bilanges; Lucia Bettedi; Wayne Pearce; Khaled Ali; Sara Sancho; Dominic J Withers; Bart Vanhaesebroeck
Journal:  EMBO Mol Med       Date:  2013-03-11       Impact factor: 12.137

View more
  24 in total

Review 1.  Constitutive and stimulated macropinocytosis in macrophages: roles in immunity and in the pathogenesis of atherosclerosis.

Authors:  Sasha A Doodnauth; Sergio Grinstein; Michelle E Maxson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-02-04       Impact factor: 6.237

Review 2.  RAS-targeted therapies: is the undruggable drugged?

Authors:  Amanda R Moore; Scott C Rosenberg; Frank McCormick; Shiva Malek
Journal:  Nat Rev Drug Discov       Date:  2020-06-11       Impact factor: 84.694

Review 3.  The PI3K Pathway in Human Disease.

Authors:  David A Fruman; Honyin Chiu; Benjamin D Hopkins; Shubha Bagrodia; Lewis C Cantley; Robert T Abraham
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

Review 4.  Cross-talk between Rho GTPases and PI3K in the neutrophil.

Authors:  Barry McCormick; Julia Y Chu; Sonja Vermeren
Journal:  Small GTPases       Date:  2017-04-17

Review 5.  PI3Kβ-A Versatile Transducer for GPCR, RTK, and Small GTPase Signaling.

Authors:  Anne R Bresnick; Jonathan M Backer
Journal:  Endocrinology       Date:  2019-03-01       Impact factor: 4.736

Review 6.  Crosstalk between the mTOR and Nrf2/ARE signaling pathways as a target in the improvement of long-term potentiation.

Authors:  Artem P Gureev; Vasily N Popov; Anatoly A Starkov
Journal:  Exp Neurol       Date:  2020-03-10       Impact factor: 5.330

7.  Gβγ signaling to the chemotactic effector P-REX1 and mammalian cell migration is directly regulated by Gαq and Gα13 proteins.

Authors:  Rodolfo Daniel Cervantes-Villagrana; Sendi Rafael Adame-García; Irving García-Jiménez; Víctor Manuel Color-Aparicio; Yarely Mabell Beltrán-Navarro; Gabriele M König; Evi Kostenis; Guadalupe Reyes-Cruz; J Silvio Gutkind; José Vázquez-Prado
Journal:  J Biol Chem       Date:  2018-11-16       Impact factor: 5.157

8.  PI3Kβ is selectively required for growth factor-stimulated macropinocytosis.

Authors:  Gilbert Salloum; Charles T Jakubik; Zahra Erami; Samantha D Heitz; Anne R Bresnick; Jonathan M Backer
Journal:  J Cell Sci       Date:  2019-08-16       Impact factor: 5.285

9.  Rac1-stimulated macropinocytosis enhances Gβγ activation of PI3Kβ.

Authors:  Zahra Erami; Bassem D Khalil; Gilbert Salloum; Yanhua Yao; Jaclyn LoPiccolo; Aliaksei Shymanets; Bernd Nürnberg; Anne R Bresnick; Jonathan M Backer
Journal:  Biochem J       Date:  2017-11-16       Impact factor: 3.857

Review 10.  MAPK and PI3K signaling: At the crossroads of neural crest development.

Authors:  Colin J Dinsmore; Philippe Soriano
Journal:  Dev Biol       Date:  2018-02-14       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.